Vaccine News and Research

Latest Vaccine News and Research

Researchers harness Zika virus vaccine under development to target glioblastoma

Researchers at The University of Texas Medical Branch at Galveston have successfully harnessed a Zika virus vaccine under development to target and kill the brain cancer known as glioblastoma.

19 Sep 2018

Zika virus vaccine shows promise for treatment of fatal glioblastoma

An international team of researchers has successfully deployed a Zika virus vaccine to target and kill human glioblastoma brain cancer stem cells, which had been transplanted into mice.

18 Sep 2018

Investigational nasal influenza vaccine tested in children and teens

An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy 9- to 17-year-old children and teens has begun enrolling participants at a Vaccine and Treatment Evaluation Unit site at Saint Louis University, St. Louis, Missouri.

17 Sep 2018

New program combines basic science and social benefits to address HIV risk among young women

A program established by investigators from the Ragon Institute of Massachusetts General Hospital, MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from two angles - first, investigating biological factors that modulate infection risk along with the early immunologic events following viral exposure, and second, alleviating the socioeconomic factors that limit opportunities for young women, the group at greatest risk of infection in the region of the world hardest hit by the HIV epidemic.

17 Sep 2018

Kids with mild or moderate adverse events following immunization can be safely reimmunized

Children who experience some type of adverse event following initial immunization have a low rate of recurrent reactions to subsequent vaccinations, reports a study in The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.

14 Sep 2018

'Nudges' may help curb decline in influenza vaccination rates as the day progresses

Primary care clinics experienced a significant decline in influenza vaccinations as the day progressed, researchers from Penn Medicine report in a new study published in JAMA Open Network.

14 Sep 2018

Most parents aren't able to recognize meningitis until it's too late

New research commissioned by GSK has shown that the majority of parents incorrectly think that a rash or stiff neck are the first signs of meningitis.

14 Sep 2018

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma -- an aggressive form of brain cancer with veryhttps://www.rush.edu/news/press-releases/rush-testing-new-brain-cancer-vaccine few current treatment options.

14 Sep 2018

Rare antibodies could be key ingredients in therapeutics capable of neutralizing many Ebola types

Two new studies by scientists at Scripps Research are bringing Ebola virus's weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the virus and stop infection--not only for Ebola virus, but for other closely related pathogens as well.

13 Sep 2018

CDC recommends people get flu shots soon

According to the Centers for Disease Control and Prevention (CDC), there have been 16 weeks of non-stop flu season last year leading to 700,000 hospitalizations due to influenza as well as pneumonias that occurred as complications.

12 Sep 2018

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy™ platform to translate and deliver first-in-class peptide-based immune therapies to people living with autoimmune diseases, today announced that it has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding the best type 1 diabetes commercial opportunities.

11 Sep 2018

Scientists develop first non-antibiotic drug to treat tuberculosis in animals

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.

11 Sep 2018

Discovery provides new hope for anti-HIV vaccine

Researchers have discovered that the RNA genome of the HIV virus can influence the immune response generated, and thus influence human survival.

10 Sep 2018

Researchers begin trial to reduce risks of major cause of childhood disabilities

Researchers are beginning recruitment in a trial to see if changing pregnant women's hygiene habits could reduce the risks of a major cause of childhood disabilities.

7 Sep 2018

Researchers test experimental cancer vaccine on mice with aggressive melanoma

An experimental cancer vaccine that boosts the immune system's ability to fight cancers could work in tandem with other cancer therapies to fight aggressive tumors, scientists reported recently in the Proceedings of the National Academy of Sciences.

7 Sep 2018

Phase 1 clinical trial examining topical cream plus influenza vaccine is underway

A Phase 1 clinical trial examining whether a topical cream can enhance the immune response conferred by a "pre-pandemic" influenza vaccine is underway at Baylor College of Medicine in Houston.

6 Sep 2018

Researchers hope to translate mRNA drugs from lab to medicine cabinet

In cells, ribosomes translate messenger RNA into proteins. And in the nascent field of mRNA therapeutics, researchers and investors are hoping to translate mRNA drugs from the lab to the medicine cabinet.

6 Sep 2018

Mouse models may not completely reflect severity of gonorrhea infection

There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.

4 Sep 2018

Researchers report challenges in reducing tetanus mortality

The overall mortality in patients suffering non-neonatal tetanus is high. Efforts to reduce mortality in one sub-Saharan African intensive care unit by implementing a standard tetanus protocol did little to change mortality rates, although they shifted causes of deaths, researchers have now reported in PLOS Neglected Tropical Diseases.

31 Aug 2018

Immunization shots effective at preventing measles

High fever. Cough. Runny nose. Red, watery eyes. It may not be the flu. It could be measles.

30 Aug 2018

Vaccine News and Research

Latest Vaccine News and Research

Researchers harness Zika virus vaccine under development to target glioblastoma

Zika virus vaccine shows promise for treatment of fatal glioblastoma

Investigational nasal influenza vaccine tested in children and teens

New program combines basic science and social benefits to address HIV risk among young women

Kids with mild or moderate adverse events following immunization can be safely reimmunized

'Nudges' may help curb decline in influenza vaccination rates as the day progresses

Most parents aren't able to recognize meningitis until it's too late

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Rare antibodies could be key ingredients in therapeutics capable of neutralizing many Ebola types

CDC recommends people get flu shots soon

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

Scientists develop first non-antibiotic drug to treat tuberculosis in animals

Discovery provides new hope for anti-HIV vaccine

Researchers begin trial to reduce risks of major cause of childhood disabilities

Researchers test experimental cancer vaccine on mice with aggressive melanoma

Phase 1 clinical trial examining topical cream plus influenza vaccine is underway

Researchers hope to translate mRNA drugs from lab to medicine cabinet

Mouse models may not completely reflect severity of gonorrhea infection

Researchers report challenges in reducing tetanus mortality

Immunization shots effective at preventing measles

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Newsletters you may be interested in